Примери за използване на Increase the prevalence на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Product characteristics(SPC), may increase the prevalence of bacteria resistant to ceftiofur.
But the levels of alcohol consumption linked to the highly charged emotional nature of those events seems to increase the prevalence of such incidents.".
Inappropriate use of the product may increase the prevalence of bacteria resistant to amoxicillin/clavulanic acid.
According to recently published data,zinc used in animal farming might increase the prevalence of antibiotic resistant bacteria due to co-selection for antimicrobial resistance genes.
A unique combination of virus-, host- and drug-related factors explains why resistance has not emerged inthe general population and also why the use of valaciclovir is unlikely to increase the prevalence of aciclovir-resistant HSV.
Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to valnemulin and may decrease the effectiveness of pleuromutilins.
Use of the product deviating from instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other fluoroquinolones due to the potential for cross-resistance.
Use of the product deviating from the instructions given in the product information may increase the prevalence of bacteria resistant to spiramycin.
Inappropriate use of the product may increase the prevalence of bacteria resistant to ß-lactam antibiotics and may decrease the effectiveness of treatment with ß-lactam antibiotics, due to the potential for cross-resistance.” Regarding the possibility for combined therapy with Synulox RTU.
Inappropriate use of the veterinary medicinal product may increase the prevalence of bacteria resistant to tiamulin.
Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease effectiveness of treatment with other quinolones due to the potential for cross resistance.
Use of the product deviating from the instructions given in the SPC may lead to treatment failures and increase the prevalence of bacteria resistant to colistin.”.
Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross resistance.
Use of the product deviating from the instructions given in the SPC increases the risk of nephrotoxicity, and may increase the prevalence of bacteria resistant to gentamicin.
Use of the product including use deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to enrofloxacin and may decrease the effectiveness of treatment with all fluoroquinolones due to the potential for cross-resistance.
Recommendations for prudent use“Official and local antimicrobial policies should be taken into account when the product is used.”“Whenever possible, quinolones should only be used based on susceptibility testing.”“Useof the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the quinolones and may decrease the effectiveness of treatment with other(fluoro)quinolones due to the potential for cross resistance.”.
Use of the product deviating from instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other fluoroquinolones due to the potential for cross-resistance.
Use of the product deviating from the instructions given in the summary of product characteristics may increase the prevalence of bacterial resistance to amoxicillin and may decrease its effectiveness.
Use of the product deviating from the instructions given in the summary of product characteristics may increase the prevalence of bacteria resistant to lincomycin and spectinomycin and may decrease the effectiveness of treatment with other antimicrobials of the same or related classes, due to the potential for cross resistance.
Use of the veterinary medicinal product deviating from the instructions given in the Summary of product characteristics(SPC)may increase the prevalence of bacteria resistant to the apramycin and may decrease the effectiveness of treatment with aminoglycosides due to the potential for cross-resistance.
Use of the veterinary medicinal product deviating from the instructions given in the SPC may increase the prevalence of bacteria and fungi resistant to gentamicin and miconazole respectively and may decrease the effectiveness of treatment with aminoglycosides and azole antifungal agents, due to the potential for cross resistance.
Use of the veterinary medicinal product deviating from instructions given in the summary of product characteristics(SPC)may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other fluoroquinolones due to the potential for crossresistance.
Use of the veterinary medicinal product deviating from the instructions given in the package leaflet may increase the prevalence of bacteria resistant to florfenicol and fungi resistant to terbinafine, and may decrease the effectiveness of treatment with other antibiotics and antifungal agents.
Use of the veterinary medicinal product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to florfenicol and fungi resistant to terbinafine and may decrease the effectiveness of treatment with other antibiotics and antifungal agents.
Use of the veterinary medicinal product deviating from the instructions given in the summary of product characteristics may increase the prevalence of bacteria resistant to the lincomycin and may decrease the effectiveness of treatment with other lincosamides, macrolides and streptogramin B due to the potential for cross-resistance.
Use of the veterinary medicinal product deviating from the instructions given in the summary of product characteristics may increase the prevalence of bacteria and fungi resistant to gentamicin and miconazole respectively and may decrease the effectiveness of treatment with aminoglycosides and azole antifungal agents, due to the potential for cross-resistance.
It also has increased the prevalence of HIV/AIDS and hepatitis.